ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 96 filers reported holding ADICET BIO INC in Q2 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $301,722 | +17.5% | 249,357 | +128.3% | 0.00% | – |
Q1 2024 | $256,716 | +230.3% | 109,241 | +709.6% | 0.00% | – |
Q1 2023 | $77,720 | -93.3% | 13,493 | -89.6% | 0.00% | -100.0% |
Q4 2022 | $1,156,952 | +553.6% | 129,413 | +853.9% | 0.01% | +100.0% |
Q1 2021 | $177,000 | -66.8% | 13,567 | -64.2% | 0.00% | -62.5% |
Q4 2020 | $533,000 | – | 37,915 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 2,115,385 | $42,160,000 | 11.96% |
Foresite Capital Management V, LLC | 680,000 | $13,580,000 | 5.55% |
Foresite Capital Opportunity Management V, LLC | 170,000 | $3,395,000 | 4.75% |
Tri Locum Partners LP | 523,256 | $10,449,000 | 4.08% |
DAFNA Capital Management LLC | 715,872 | $14,296,000 | 3.72% |
Decheng Capital Management III (Cayman), LLC | 580,000 | $11,583,000 | 3.55% |
COWEN AND COMPANY, LLC | 1,500,055 | $29,956,000 | 2.88% |
JOHNSON & JOHNSON | 728,944 | $14,557,000 | 2.75% |
Orbimed Advisors | 7,447,141 | $148,719,000 | 2.41% |
Ikarian Capital, LLC | 507,348 | $10,132,000 | 1.33% |